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Purpose or Objective: Treatment planning for volumetric 
modulated arc therapy (VMAT) is complex, as the result is 
highly dependent on the selected optimization objectives. 
The Auto-Planning module in Pinnacle³ 9.10 (Philips 
Healthcare, Fitchburg, WI, USA) aims at offering efficient 
automated planning that directly uses clinical goals for 
iterative optimization, pushes beyond these goals if possible, 
and delivers consistent plan quality. In this study, we 
compared the performance of two Auto-Planning techniques 
with our original clinical approach of manually optimized 
prostate cancer VMAT plans. 
 
Material and Methods: Techniques were evaluated for 23 
prostate cancer patients (all treated using a rectal balloon), 
18 of which underwent primary irradiation with a prescription 
dose (PD) of 70 Gy in 28 fractions. PTV (planning target 
volume) for these cases ranged from prostate only to 
prostate plus entire seminal vesicles. Five patients received 
salvage treatment with 65 Gy in 26 fractions.  
Two Auto-Planning techniques (AP1, AP2) were compared 
with the manually optimized clinical plan (MP) to evaluate 
plan quality, focusing on PTV coverage and OAR (organ at 
risk) sparing. AP1 contained clinical goals for rectal wall, anal 
wall, bladder and femoral heads (dose-volume relationship 
and mean dose goals). AP2 used the same technique, 
excluding the femoral heads, in order to focus on bladder, 
rectal and anal wall (which are more prone to toxicity), and 
including a goal to minimize dose on tissue outside PTV and 
OARs.  
Monitor units (MUs) for all plans were scaled to achieve a 
V95% ≥ 99% for the PTV. One 10 MV VMAT arc (95 to 265° 
counterclockwise) and two portal imaging beams (for online 
position verification, 5 MU each) were used.  
 
Results: Table 1 presents the results of the comparison. Both 
AP techniques show a significant increase in PTV mean dose 
and number of MU when compared to MP, while PTV max 
dose is not significantly different. With respect to OARs, 
Auto-Planning significantly spares all considered structures. 
AP2 indeed sacrifices sparing of femoral heads for more 
sparing of bladder, rectal and anal wall. See Figure 1 for an 
example of dose distributions and DVHs (dose volume 
histograms).  
We selected AP2 as our Auto-Planning technique for clinical 
use. For 10 subsequently treated patients, AP2 resulted in an 
approved plan on the first Auto-Planning run for all 8 patients 
undergoing primary irradiation. The 2 salvage patients 
needed extra goals for the femoral heads. 
Delta-4 measurements for 20 patients treated with AP2 
showed a mean gamma pass rate of 98.4 ± 1.4 %, while EBT3 
film QA on a subset of 10 patients resulted in a mean gamma 
pass rate of 97.4 ± 1.2 % (evaluated for 3%/3mm). 
 
Conclusion: Besides its efficiency and consistency, Auto-
Planning offers similar PTV coverage as the original clinical 
plans, combined with better sparing of bladder, rectal and 
anal wall. Thus, the module widens the therapeutic window 
and is now used as our clinical standard for prostate cancer 
VMAT planning.  
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Purpose or Objective: The modulated arc (mARC) technique 
is Siemens analogue to volumetric modulated arc therapy 
(VMAT), with a different underlying principle and technical 
implementation. While this presents the only available 
rotational technique for existing Siemens users, only few 
treatment planning systems (TPS) are capable of mARC 
planning. In particular, the widespread Philips Pinnacle TPS 
does not support mARC. The purpose of this work is to 
present two solutions for mARC plan creation starting from 
either IMRT or SmartArc plans. 
 
Material and Methods: In the first approach, the user creates 
a step-and-shoot IMRT plan with any number of beams 
ordered either clockwise or counter-clockwise, and one 
segment per beam. If desired, a few beams with more than 
one segment can be included. This plan is then exported as 
RT-Dose and an in-house software is used to modify the file in 
such a way that it is interpreted by the linac as an mARC 
plan. For this aim, each single-segment beam is converted 
into an arclet of a user-specified length (usually 4°). The 
calculated dose distribution of the IMRT plan corresponds to 
the mARC treatment, because mARC dose is usually 
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calculated under the assumption of stationary arclet 
delivery.  
The second method is a dedicated solution for mARC planning 
in Philips Pinnacle (V9.2 or higher) without the detour of an 
external software. In this approach, a SmartArc (VMAT) plan 
is created in the TPS with 8° final spacing of optimization 
points. Then a Pinnacle script is applied which duplicates and 
shifts the optimization points in such a way to separate 
phases of beam on and of MLC movement. This resulting plan 
is still treated like a SmartArc plan in the TPS, but irradiated 
as mARC at the linac.  
We present the proof-of-principle and dosimetric verification 
using the PTW Octavius rotation unit with 2D-array. 
 
Results: A number of plans were created for prostate and 
head-and-neck cancer. All converted plans could be 
irradiated without problems. 3D dose distributions agree with 
the calculated dose distributions (mARC and approximated 
stationary field plan) within the gamma criteria for IMRT 
verification (over 90 % of the points passing the criteria of 3 
% deviation in local dose, 3 mm distance to agreement, for 
all dose values above 10 % of the maximum, example in 
Figure). 
 
 
 
 
Conclusion: Both solutions offer the possibility of mARC 
planning inside a non-dedicated TPS. If Philips Pinnacle with 
SmartArc is available, plan creation is straightforward and 
can be performed inside the TPS. Otherwise, a special format 
of IMRT plan is required, which is externally modified before 
treatment. In both cases, good dosimetric accuracy is 
achieved, making this a viable solution for the creation of 
mARC treatment plans inside any treatment planning system. 
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Purpose or Objective: The achievable PTV coverage of spinal 
SBRT treatment plans depends on the spatial relationship 
between cord and target. PTV coverage is often sacrificed to 
fulfill the cord constraints and there are no objective criteria 
to determine whether an optimal coverage has been 
achieved. This may lead to suboptimal plan quality and to 
dependence on the planner’s experience. A method to 
predict the achievable PTV coverage is proposed, which is 
based on an existing database and on a geometric parameter 
related to the cord-target 3D distance. 
 
Material and Methods: A clinical database of 70 spine SBRT 
plans, 41 first treatment and 29 retreatment cases, delivered 
by the Cyberknife either in 3 fractions or in one fraction is 
used. TG101 cord constraints or stricter limits for 
reirradiation were applied. The 3D distance of cord to target 
was quantified by the expansion-intersection volume (EIV) 
[M.Descovich (2013)] adapted to spine and calculated as the 
intersection of the CTV and the cord, both expanded by 5 
mm. Plans were classified into 3 groups according to the ratio 
of the prescribed dose to the cord maximum dose 
(PD/cordDmax): 1) 1.1-1.65; 2) 1.66-1.9; 3) 1.91-2.9. For 
each group the correlation between EIV and the PTV 
coverage was studied, analyzing the linear regression 
between EIV and the uncovered target volume (PTVout). As 
validation EIV was calculated for 20 new cases, the expected 
PTVout value computed by the regression equation and the 
plans optimized aiming to obtain the predicted coverage 
respecting the OAR constraints. 
 
Results: EIV values ranged from 0.3 to 18 cc indicating a 
representative sample of the possible anatomical 
configurations. Average PTV coverage was 91.2% (range 81.5- 
98.6%). A significant (p< 0.01) positive correlation (Pearson’s 
r>0.67) was observed between EIV and the uncovered PTV 
(PTVout) over the 3 groups, confirming that for larger EIV, 
lower coverages are expected. The slope of the 3 respective 
regression lines increased from 0.67 to 0. 8 for increasing 
PD/cordDmax. For 16 out of the 20 new plans PTV coverage 
was higher than the predicted value, i.e PTVout was below 
the regression line (fig.1) fulfilling the optimization purpose. 
 
 
Conclusion: This study confirms that EIV is a good parameter 
to represent the cord-target 3D distance in spinal SBRT. The 
analysis accounted for the interplay between anatomical 
characteristics and required dose gradient. The results 
